Vandria begins clinical trials for Alzheimer’s drug VNA-318
Vandria begins clinical trials for Alzheimer’s drug VNA-318
7 January 2025
GGBA Read news
http://preview.vandria.com/wp-content/uploads/2025/11/Vandria-Logo-RGB-Color.svg00Webadnhttp://preview.vandria.com/wp-content/uploads/2025/11/Vandria-Logo-RGB-Color.svgWebadn2025-01-07 16:39:112025-12-01 18:11:24Vandria begins clinical trials for Alzheimer’s drug VNA-318
